Platelet GPIIb/IIIa Receptor Antagonists in Human Ischemic Brain Disease

By  

Current Vascular Pharmacology, Vol. 6, Iss. 1, 2008-01 ,pp. : 29-36

Bentham Science Publishers

Access to resources Recommend Favorite

GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly

By A. May H. Ratan J. R. Glenn W. Losche P. Spangenberg S. Heptinstall J.  

Platelets, Vol. 9, Iss. 3-4, 1998-07 ,pp. : 227-232

Informa Healthcare

Access to resources Recommend Favorite

Progress in the Field of GPIIb/IIIa Antagonists

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 2, 2004-04 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite

Comparison of the Effect of Different Platelet GPIIb/IIIa Antagonists on the Dynamics of Platelet/Fibrin-Mediated Clot Strength Induced Using Thromboelastography

By Mousa S.A.   Forsythe M.S.  

Thrombosis Research, Vol. 104, Iss. 1, 2001-10 ,pp. : 49-56

Elsevier

Access to resources Recommend Favorite

The Use of the Point of Care Helena ICHOR/Plateletworks® and the Accumetrics Ultegra® RPFA for Assessment of Platelet Function with GPIIb-IIIa Antagonists

By White Melanie   Krishnan Rajini   Kueter Teddi   Jacoski Mary   Jennings Lisa  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 3, 2004-12 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite